Proteolytic activation of angiomotin by DDI2 promotes angiogenesis

Yu Wang,Yuwen Zhu,Yebin Wang,Yue Chang,Fang Geng,Mingyue Ma,Yuan Gu,Aijuan Yu,Rui Zhu,Pengcheng Yu,Zhao Sha,Sixian Qi,Jian Li,Wencao Zhao,Weijun Pan,Ruilin Zhang,Fa‐Xing Yu
DOI: https://doi.org/10.15252/embj.2022112900
2023-06-24
The EMBO Journal
Abstract:Cleavage of the scaffold protein AMOT promotes vascular expansion in a manner modulated by membrane localization, poly ADP‐ribosylation, and ubiquitination. The scaffolding protein angiomotin (AMOT) is indispensable for vertebrate embryonic angiogenesis. Here, we report that AMOT undergoes cleavage in the presence of lysophosphatidic acid (LPA), a lipid growth factor also involved in angiogenesis. AMOT cleavage is mediated by aspartic protease DNA damage‐inducible 1 homolog 2 (DDI2), and the process is tightly regulated by a signaling axis including neurofibromin 2 (NF2), tankyrase 1/2 (TNKS1/2), and RING finger protein 146 (RNF146), which induce AMOT membrane localization, poly ADP ribosylation, and ubiquitination, respectively. In both zebrafish and mice, the genetic inactivation of AMOT cleavage regulators leads to defective angiogenesis, and the phenotype is rescued by the overexpression of AMOT‐CT, a C‐terminal AMOT cleavage product. In either physiological or pathological angiogenesis, AMOT‐CT is required for vascular expansion, whereas uncleavable AMOT represses this process. Thus, our work uncovers a signaling pathway that regulates angiogenesis by modulating a cleavage‐dependent activation of AMOT.
What problem does this paper attempt to address?